Caplin Point Laboratories, 524742, CAPLIPOINT Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9,819.52
23.50
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,255.51
0.35%
4.74

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
17.72
11.39

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
13.70
6.32

PAT CAGR (%)

10 Years
5 Years
3 Years

-
16.34
15.81

P:E (Median)

8 Years
5 Years
3 Years

19.85
17.65
18.47

P:BV (Average)

8 Years
5 Years
3 Years

7.95
4.07
3.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.97
11.67
12.47

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 179.22 136.95 30.87% 173.66 116.39 49.21% 144.67 111.94 29.24% 130.60 128.22 1.86%
Expenses 89.77 79.53 12.88% 97.04 70.28 38.08% 79.80 73.53 8.53% 79.09 74.74 5.82%
EBITDA 89.45 57.42 55.78% 76.62 46.11 66.17% 64.87 38.41 68.89% 51.51 53.48 -3.68%
EBIDTM 49.91% 41.93% 44.12% 39.62% 44.84% 34.31% 39.44% 41.71%
Other Income 24.49 22.45 9.09% 27.27 34.97 -22.02% 12.22 10.26 19.10% 29.36 8.54 243.79%
Interest 0.02 0.04 -50.00% 0.03 0.01 200.00% 0.03 0.02 50.00% 0.04 0.02 100.00%
Depreciation 6.72 6.51 3.23% 6.67 6.37 4.71% 6.29 6.95 -9.50% 6.47 6.31 2.54%
PBT 107.20 73.32 46.21% 97.19 74.70 30.11% 70.77 41.70 69.71% 74.36 55.69 33.52%
Tax 25.10 15.81 58.76% 20.92 11.46 82.55% 16.44 12.68 29.65% 15.19 16.57 -8.33%
PAT 82.10 57.51 42.76% 76.27 63.24 20.60% 54.33 29.02 87.22% 59.17 39.12 51.25%
PATM 45.81% 41.99% 43.92% 54.33% 37.55% 25.92% 45.31% 30.51%
EPS 10.82 7.58 42.74% 10.05 8.33 20.65% 7.16 3.82 87.43% 7.80 5.15 51.46%

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 410.06 359.05 14.21% 395.32 346.33 14.15% 389.28 339.24 14.75% 372.07 326.20 14.06%
Expenses 272.66 253.47 7.57% 268.79 244.15 10.09% 265.35 239.30 10.89% 262.70 225.24 16.63%
EBITDA 137.40 105.58 30.14% 126.53 102.18 23.83% 123.93 99.94 24.00% 109.37 100.96 8.33%
EBIDTM 33.51% 29.41% 32.01% 29.50% 31.84% 29.46% 29.39% 30.95%
Other Income 20.43 16.48 23.97% 12.04 13.94 -13.63% 11.40 11.51 -0.96% 14.15 9.54 48.32%
Interest 0.18 0.14 28.57% 0.28 0.06 366.67% 0.23 0.08 187.50% 0.36 0.14 157.14%
Depreciation 11.76 11.46 2.62% 11.38 10.97 3.74% 11.13 11.45 -2.79% 11.43 11.70 -2.31%
PBT 145.89 110.46 32.07% 126.91 105.09 20.76% 123.97 99.92 24.07% 111.73 98.66 13.25%
Tax 29.86 18.42 62.11% 22.76 18.78 21.19% 22.81 19.09 19.49% 14.35 19.38 -25.95%
PAT 116.03 92.04 26.06% 104.15 86.31 20.67% 101.16 80.83 25.15% 97.38 79.28 22.83%
PATM 28.30% 25.63% 26.35% 24.92% 25.99% 23.83% 26.17% 24.30%
EPS 15.12 12.09 25.06% 13.62 11.21 21.50% 13.45 10.43 28.95% 12.84 9.89 29.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Net Sales 628.15 528.61 528.06 482.68 527.83 536.91 426.57 341.55 231.29 240.23 166.40 Net Sales Growth 27.28% 0.10% 9.40% -8.55% -1.69% 25.87% 24.89% 47.67% -3.72% 44.37% Cost Of Goods Sold 227.58 198.06 204.65 194.83 238.18 237.03 180.11 161.94 116.73 128.25 99.74 Gross Profit 400.57 330.55 323.41 287.85 289.65 299.87 246.46 179.61 114.56 111.98 66.66 GP Margin 63.77% 62.53% 61.24% 59.64% 54.88% 55.85% 57.78% 52.59% 49.53% 46.61% 40.06% Total Expenditure 345.70 309.23 308.58 273.14 320.83 348.31 284.33 247.72 168.78 183.03 132.31 Power & Fuel Cost - 9.89 9.54 6.36 7.19 12.29 10.96 9.85 7.55 8.39 2.83 % Of Sales - 1.87% 1.81% 1.32% 1.36% 2.29% 2.57% 2.88% 3.26% 3.49% 1.70% Employee Cost - 35.81 29.91 26.03 24.39 40.49 37.29 29.48 17.58 17.84 12.25 % Of Sales - 6.77% 5.66% 5.39% 4.62% 7.54% 8.74% 8.63% 7.60% 7.43% 7.36% Manufacturing Exp. - 42.18 34.68 27.15 33.34 38.72 37.02 28.34 13.84 15.59 7.10 % Of Sales - 7.98% 6.57% 5.62% 6.32% 7.21% 8.68% 8.30% 5.98% 6.49% 4.27% General & Admin Exp. - 8.80 7.97 6.50 8.55 14.96 12.18 12.63 7.60 7.43 5.88 % Of Sales - 1.66% 1.51% 1.35% 1.62% 2.79% 2.86% 3.70% 3.29% 3.09% 3.53% Selling & Distn. Exp. - 3.91 12.23 2.78 5.89 2.64 4.74 5.37 2.11 2.62 1.31 % Of Sales - 0.74% 2.32% 0.58% 1.12% 0.49% 1.11% 1.57% 0.91% 1.09% 0.79% Miscellaneous Exp. - 10.58 9.60 9.49 3.29 2.17 2.03 0.11 3.38 2.91 1.31 % Of Sales - 2.00% 1.82% 1.97% 0.62% 0.40% 0.48% 0.03% 1.46% 1.21% 1.92% EBITDA 282.45 219.38 219.48 209.54 207.00 188.60 142.24 93.83 62.51 57.20 34.09 EBITDA Margin 44.97% 41.50% 41.56% 43.41% 39.22% 35.13% 33.35% 27.47% 27.03% 23.81% 20.49% Other Income 93.34 99.54 56.69 23.01 65.97 35.40 23.31 12.51 3.47 2.74 3.34 Interest 0.12 0.12 0.09 0.17 0.19 0.50 0.52 0.50 0.31 0.87 0.61 Depreciation 26.15 25.65 25.77 22.44 19.65 20.84 18.99 13.26 7.30 8.28 3.44 PBT 349.52 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 33.38 Tax 77.65 58.89 62.44 53.71 55.49 54.49 43.74 22.26 13.05 9.86 7.74 Tax Rate 22.22% 20.09% 24.95% 25.58% 21.92% 26.89% 29.95% 24.04% 22.35% 19.41% 23.19% PAT 271.87 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 25.64 PAT before Minority Interest 271.87 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 40.94 25.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 43.28% 44.32% 35.58% 32.37% 37.44% 27.60% 23.98% 20.59% 19.60% 17.04% 15.41% PAT Growth 43.93% 24.69% 20.25% -20.95% 33.39% 44.82% 45.49% 55.13% 10.72% 59.67% EPS 35.82 30.86 24.75 20.58 26.04 19.52 13.48 9.26 5.97 5.39 3.38

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Net Sales 1,566.73 1,466.73 1,269.41 1,061.29 863.20 648.69 539.84 401.65 238.72 251.77 173.09 Net Sales Growth 14.29% 15.54% 19.61% 22.95% 33.07% 20.16% 34.41% 68.25% -5.18% 45.46% Cost Of Goods Sold 683.20 663.21 557.51 471.74 413.16 288.78 238.18 184.93 121.16 135.62 102.58 Gross Profit 883.53 803.52 711.90 589.55 450.04 359.91 301.66 216.72 117.56 116.15 70.50 GP Margin 56.39% 54.78% 56.08% 55.55% 52.14% 55.48% 55.88% 53.96% 49.25% 46.13% 40.73% Total Expenditure 1,069.50 1,026.21 874.88 737.04 603.13 416.84 344.52 276.84 174.51 192.06 136.90 Power & Fuel Cost - 25.53 21.40 16.36 14.81 13.76 10.98 9.91 7.56 8.61 3.07 % Of Sales - 1.74% 1.69% 1.54% 1.72% 2.12% 2.03% 2.47% 3.17% 3.42% 1.77% Employee Cost - 136.12 114.74 101.97 67.15 45.58 37.61 29.71 17.92 18.24 12.63 % Of Sales - 9.28% 9.04% 9.61% 7.78% 7.03% 6.97% 7.40% 7.51% 7.24% 7.30% Manufacturing Exp. - 90.99 82.01 69.85 68.23 43.49 37.11 28.56 14.33 16.04 7.42 % Of Sales - 6.20% 6.46% 6.58% 7.90% 6.70% 6.87% 7.11% 6.00% 6.37% 4.29% General & Admin Exp. - 62.98 49.16 38.53 25.50 20.82 12.27 13.78 8.15 7.97 6.54 % Of Sales - 4.29% 3.87% 3.63% 2.95% 3.21% 2.27% 3.43% 3.41% 3.17% 3.78% Selling & Distn. Exp. - 18.78 27.52 18.03 9.95 2.08 5.92 9.41 2.29 2.85 1.46 % Of Sales - 1.28% 2.17% 1.70% 1.15% 0.32% 1.10% 2.34% 0.96% 1.13% 0.84% Miscellaneous Exp. - 28.60 22.54 20.56 4.33 2.33 2.45 0.55 3.10 2.72 1.46 % Of Sales - 1.95% 1.78% 1.94% 0.50% 0.36% 0.45% 0.14% 1.30% 1.08% 1.84% EBITDA 497.23 440.52 394.53 324.25 260.07 231.85 195.32 124.81 64.21 59.71 36.19 EBITDA Margin 31.74% 30.03% 31.08% 30.55% 30.13% 35.74% 36.18% 31.07% 26.90% 23.72% 20.91% Other Income 58.02 56.52 38.89 27.93 41.33 19.03 12.67 9.96 3.66 3.03 3.72 Interest 1.05 0.78 0.70 1.59 0.32 0.58 0.61 0.52 0.34 0.97 0.68 Depreciation 45.70 44.99 46.90 36.97 31.62 23.43 19.00 13.30 7.48 8.38 3.54 PBT 508.50 451.27 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 35.69 Tax 89.78 74.36 77.37 62.19 54.38 50.32 43.74 25.44 14.28 12.26 9.76 Tax Rate 17.66% 16.48% 20.05% 19.83% 20.18% 22.18% 23.22% 21.03% 23.78% 22.96% 27.35% PAT 418.72 376.26 299.84 242.27 215.00 176.56 144.78 95.61 45.77 41.04 25.85 PAT before Minority Interest 417.61 376.99 308.45 251.43 215.08 176.56 144.63 95.50 45.77 41.13 25.93 Minority Interest -1.11 -0.73 -8.61 -9.16 -0.08 0.00 0.15 0.11 0.00 -0.09 -0.08 PAT Margin 26.73% 25.65% 23.62% 22.83% 24.91% 27.22% 26.82% 23.80% 19.17% 16.30% 14.93% PAT Growth 23.71% 25.49% 23.76% 12.68% 21.77% 21.95% 51.43% 108.89% 11.53% 58.76% EPS 55.17 49.57 39.50 31.92 28.33 23.26 19.08 12.60 6.03 5.41 3.41

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Shareholder's Funds 1,139.91 930.65 758.67 599.91 432.04 295.60 200.12 128.14 93.63 62.28 Share Capital 15.18 15.16 15.13 15.13 15.13 15.12 15.12 15.11 15.11 15.11 Total Reserves 1,109.36 900.04 728.75 575.34 410.06 277.19 184.91 111.40 78.52 47.17 Non-Current Liabilities 16.42 24.63 24.99 27.16 24.77 27.86 19.90 13.69 10.39 10.37 Secured Loans 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 2.02 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.40 1.63 0.82 0.81 Current Liabilities 146.85 98.88 77.33 64.26 82.51 87.34 97.05 120.77 119.18 101.56 Trade Payables 81.42 65.02 70.11 51.41 59.50 72.89 66.01 51.47 38.04 27.45 Other Current Liabilities 65.26 32.66 6.06 11.97 21.76 13.86 29.37 60.37 71.36 65.73 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.05 Short Term Provisions 0.17 1.20 1.16 0.87 1.25 0.58 1.67 8.92 9.73 8.33 Total Liabilities 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.20 174.21 Net Block 156.85 162.46 182.68 166.93 137.77 169.32 151.75 142.75 111.47 100.51 Gross Block 285.13 268.64 266.22 228.35 179.85 231.63 195.07 178.70 140.64 121.01 Accumulated Depreciation 128.28 106.18 83.54 61.43 42.08 62.31 43.32 35.94 29.17 20.51 Non Current Assets 639.20 448.49 348.35 310.59 251.37 197.59 180.34 147.78 146.11 129.50 Capital Work in Progress 42.68 2.60 1.36 3.77 8.62 15.29 3.42 0.23 30.63 24.54 Non Current Investment 274.97 212.73 138.64 135.54 98.62 1.87 14.58 1.43 1.44 0.54 Long Term Loans & Adv. 164.70 70.70 5.67 4.36 6.36 11.11 10.59 3.37 2.57 3.49 Other Non Current Assets 0.00 0.00 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 663.98 605.67 512.64 380.74 287.95 213.21 136.73 114.82 77.10 44.71 Current Investments 159.17 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 0.00 Inventories 51.53 42.81 24.87 22.37 23.52 28.46 22.29 17.90 12.66 7.81 Sundry Debtors 88.24 53.73 98.46 218.98 125.39 86.35 3.21 6.80 0.02 0.01 Cash & Bank 271.38 316.08 345.49 58.27 44.85 28.28 76.66 64.77 40.32 23.17 Other Current Assets 93.66 11.97 18.31 10.32 24.56 23.78 30.37 25.35 24.10 13.73 Short Term Loans & Adv. 72.24 129.11 14.97 10.57 15.95 17.00 23.05 14.93 18.59 10.59 Net Current Assets 517.13 506.79 435.31 316.48 205.44 125.87 39.67 -5.95 -42.08 -56.85 Total Assets 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 223.21 174.21

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Shareholder's Funds 1,880.48 1,483.93 1,185.83 947.91 632.91 363.83 224.76 128.14 93.19 61.74 Share Capital 89.76 89.74 89.71 89.71 51.05 15.12 15.12 15.11 15.11 15.11 Total Reserves 1,775.35 1,378.74 1,081.33 848.76 575.01 345.42 209.56 111.40 78.08 46.63 Non-Current Liabilities 2.30 12.55 17.39 24.86 23.42 27.86 19.90 13.69 10.39 10.42 Secured Loans 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 0.88 2.07 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 7.78 8.48 5.69 5.23 0.13 0.00 0.40 1.63 0.82 0.81 Current Liabilities 268.00 207.68 142.85 144.32 86.11 108.67 113.36 125.04 124.97 107.58 Trade Payables 164.37 155.94 88.50 64.14 60.47 94.23 78.60 55.71 41.56 31.50 Other Current Liabilities 99.94 48.68 51.87 79.28 24.20 13.86 33.09 60.39 72.11 66.42 Short Term Borrowings 3.41 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.05 Short Term Provisions 0.28 2.56 2.48 0.91 1.44 0.58 1.67 8.94 11.25 9.60 Total Liabilities 2,177.57 1,730.11 1,363.61 1,125.75 742.52 500.45 358.38 267.14 228.82 179.92 Net Block 279.81 286.57 305.34 272.50 226.84 169.48 151.83 144.23 113.13 102.24 Gross Block 480.32 445.74 422.58 354.79 271.51 231.79 195.15 180.76 142.71 123.06 Accumulated Depreciation 200.51 159.17 117.24 82.29 44.67 62.31 43.31 36.53 29.58 20.82 Non Current Assets 623.11 432.29 349.04 303.23 248.83 196.34 179.16 148.61 146.95 131.30 Capital Work in Progress 220.71 17.73 13.88 20.12 9.70 15.29 3.42 0.23 30.63 24.54 Non Current Investment 70.52 37.01 0.66 0.56 0.33 0.33 13.24 0.44 0.45 0.44 Long Term Loans & Adv. 51.68 89.90 7.92 10.05 11.95 11.23 10.67 3.71 2.75 3.67 Other Non Current Assets 0.39 1.08 21.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,554.46 1,297.82 1,014.57 822.53 493.69 304.11 179.22 118.53 81.87 48.61 Current Investments 159.17 51.97 10.54 60.23 69.62 46.34 4.20 0.00 0.00 0.00 Inventories 288.22 227.31 179.01 238.23 37.45 28.46 22.29 18.81 13.66 9.79 Sundry Debtors 394.06 317.05 279.36 228.96 159.81 125.88 33.02 7.95 5.66 0.09 Cash & Bank 493.48 462.99 438.33 223.43 152.99 79.28 93.07 68.10 45.37 26.82 Other Current Assets 219.53 17.28 20.25 14.87 73.83 24.16 26.63 23.67 17.18 11.90 Short Term Loans & Adv. 192.21 221.22 87.08 56.81 64.61 17.28 19.31 12.58 11.08 8.16 Net Current Assets 1,286.46 1,090.14 871.72 678.21 407.58 195.44 65.86 -6.51 -43.10 -58.97 Total Assets 2,177.57 1,730.11 1,363.61 1,125.76 742.52 500.45 358.38 267.14 228.82 179.91

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Cash From Operating Activity 157.10 230.97 294.64 87.01 107.34 22.61 55.49 44.37 49.53 59.77 PBT 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 50.80 33.38 Adjustment -59.57 -19.43 7.75 -32.58 -0.29 3.44 8.06 3.89 6.32 2.28 Changes in Working Capital -11.45 62.07 131.85 -83.19 -54.17 -92.59 -24.76 -7.20 1.91 29.55 Cash after chg. in Working capital 222.13 292.95 349.54 137.36 148.19 56.90 75.88 55.07 59.03 65.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -65.03 -61.98 -54.90 -50.35 -40.84 -34.29 -20.39 -10.69 -9.50 -5.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -86.67 -275.93 -3.71 -41.06 -76.51 -59.71 -37.07 -5.98 -23.76 -44.08 Net Fixed Assets -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 -48.50 Net Investments -169.44 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 0.75 Others 139.34 -156.75 -14.84 30.12 -14.93 18.15 -0.16 1.67 2.86 3.67 Cash from Financing Activity -30.42 -22.76 -3.47 -32.92 -15.21 -11.60 -6.74 -13.95 -8.62 -5.97 Net Cash Inflow / Outflow 40.01 -67.72 287.46 13.03 15.62 -48.70 11.67 24.45 17.15 9.72 Opening Cash & Equivalents 81.01 148.82 55.61 42.52 26.18 74.89 63.22 40.32 23.17 13.45 Closing Cash & Equivalent 122.02 81.01 342.88 55.61 42.52 26.18 74.89 64.77 40.32 23.17

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Cash From Operating Activity 271.37 336.73 268.61 44.68 83.42 66.49 67.61 42.40 49.88 59.83 PBT 451.35 385.82 313.62 269.46 226.88 188.38 120.95 60.05 53.39 35.69 Adjustment 11.77 30.44 23.09 7.09 19.12 14.84 8.61 3.87 6.21 2.14 Changes in Working Capital -103.75 1.96 -1.96 -177.11 -120.06 -100.38 -38.39 -5.13 1.96 29.32 Cash after chg. in Working capital 359.37 418.22 334.75 99.44 125.94 102.84 91.16 58.78 61.56 67.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -88.00 -81.49 -66.14 -54.76 -42.51 -36.35 -23.55 -16.38 -11.67 -7.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -217.58 -376.77 -29.44 -54.50 -100.46 -69.02 -36.11 -5.72 -22.66 -43.89 Net Fixed Assets -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 -25.72 -48.50 Net Investments -169.44 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 -0.90 0.75 Others 8.43 -257.59 -40.57 16.68 -38.88 8.84 0.80 1.93 3.96 3.86 Cash from Financing Activity -28.17 -40.68 -23.98 79.77 89.79 -11.60 -6.74 -13.95 -8.67 -5.96 Net Cash Inflow / Outflow 25.62 -80.72 215.19 69.94 72.76 -14.13 24.76 22.73 18.55 9.99 Opening Cash & Equivalents 150.76 231.57 220.77 150.65 77.17 91.31 66.55 45.37 26.82 16.84 Closing Cash & Equivalent 177.56 150.76 435.72 220.77 150.65 77.17 91.31 68.10 45.37 26.82

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Book Value (Rs.) 148.16 120.74 98.33 78.06 56.22 38.66 26.47 16.25 11.90 7.75 ROA 19.87% 19.62% 20.13% 32.12% 31.19% 28.11% 24.26% 18.66% 20.60% 16.96% ROE 22.97% 22.65% 23.42% 38.92% 41.30% 41.56% 43.57% 42.62% 55.15% 51.94% ROCE 28.33% 29.64% 30.92% 49.05% 55.76% 58.99% 56.89% 53.75% 67.20% 63.77% Fixed Asset Turnover 1.91 1.97 1.95 2.59 2.61 2.00 1.83 1.45 1.84 1.97 Receivable days 49.01 52.60 120.02 119.07 71.97 38.32 5.35 5.38 0.02 0.67 Inventory Days 32.57 23.39 17.86 15.87 17.67 21.71 21.48 24.11 15.55 18.34 Payable days 134.94 120.50 113.83 61.02 67.67 86.81 85.61 98.57 65.47 71.75 Cash Conversion Cycle -53.35 -44.52 24.05 73.91 21.97 -26.78 -58.79 -69.08 -49.90 -52.74 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.06 Interest Cover 2443.92 2782.22 1235.94 1369.24 404.61 281.22 185.02 190.79 59.55 55.62

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Book Value (Rs.) 235.91 183.89 144.94 114.21 78.03 47.69 29.73 16.25 11.84 7.68 ROA 19.29% 19.94% 20.20% 23.02% 28.41% 33.68% 30.54% 18.46% 20.12% 16.48% ROE 23.68% 24.77% 25.65% 29.58% 37.14% 49.43% 54.97% 43.13% 55.78% 53.24% ROCE 26.85% 28.77% 28.82% 33.35% 45.59% 64.08% 69.03% 55.41% 71.11% 68.99% Fixed Asset Turnover 3.17 2.92 2.73 2.76 2.58 2.53 2.14 1.48 1.89 2.00 Receivable days 88.48 85.74 87.41 82.19 80.37 53.72 18.62 10.40 4.17 1.00 Inventory Days 64.15 58.42 71.75 58.28 18.54 17.16 18.68 24.83 17.00 21.31 Payable days 88.14 80.02 59.05 28.33 65.76 89.68 88.17 103.48 69.75 79.69 Cash Conversion Cycle 64.48 64.14 100.11 112.15 33.15 -18.80 -50.88 -68.24 -48.58 -57.39 Total Debt/Equity 0.00 0.00 0.01 0.04 0.00 0.00 0.00 0.02 0.02 0.06 Interest Cover 579.65 552.17 198.25 843.86 391.22 309.72 235.08 179.35 56.11 53.29

Top Investors:

investor education and protection fund authority ministry of corporate affairs

suresh kumar agarwal

llp

Annual Reports:

News Update:

Caplin Point Lab - Quarterly Results
9th Nov 2023, 12:43 PM

Read More
Caplin Point Laboratories’ arm gets USFDA’s final approval for Norepinephrine Bitartrate Injection
20th Sep 2023, 14:12 PM

Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients with acute hypotensive states
Read More
Caplin Point Laboratories’ arm gets EIR from USFDA for Chennai unit
4th Sep 2023, 12:42 PM

The unit underwent an inspection from USFDA during May 22- May 31
Read More

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: